A 2-Part, Phase 1, Single and Multiple Ascending Dose Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of CAT-2054 in Healthy Subjects
Clinical trial NCT02374047 · COMPLETED
Trial details
- NCT number
- NCT02374047
- Sponsor
- Catabasis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-01
- Primary completion
- 2015-07-01
- Enrollment
- 118
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.